Search

Your search keyword '"Mamah, D"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Mamah, D" Remove constraint Author: "Mamah, D"
73 results on '"Mamah, D"'

Search Results

1. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

2. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

10. Diffusion Basis Spectrum Imaging of White Matter in Schizophrenia and Bipolar Disorder.

11. Kenya Psychosis-Risk Outcomes Study (KePROS): Development of an Accelerated Medicine Partnership Schizophrenia-Aligned Project in Africa.

12. Psychotic-like experiences and adverse life events in young people. Does gender matter?

13. Epidemiology of DSM-5 psychiatric disorders in Kenyan Youth with Low and High Psychosis Risk.

14. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

15. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

16. Tract-based analyses of white matter in schizophrenia, bipolar disorder, aging, and dementia using high spatial and directional resolution diffusion imaging: a pilot study.

17. DSM-5 conduct disorder and symptoms in youths at high risk of psychosis in Kenya with DSM-5 mental disorders and substance use: towards integrated management.

18. Risk of autism spectrum disorder and association of its symptoms with psychiatric and substance use disorders in non-clinical student sample in Kenya: cross-sectional study.

19. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

20. The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia.

21. Students stress patterns in a Kenyan socio-cultural and economic context: toward a public health intervention.

22. A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk.

23. Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue.

24. Socio-demographic, economic and mental health problems were risk factors for suicidal ideation among Kenyan students aged 15 plus.

25. Prevalence and perception of substance abuse and associated economic indicators and mental health disorders in a large cohort of Kenyan students: towards integrated public health approach and clinical management.

26. Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion.

27. The prevalance of binge eating disorder and associated psychiatric and substance use disorders in a student population in Kenya - towards a public health approach.

28. A population-based survey of autistic traits in Kenyan adolescents and young adults.

29. Basal ganglia shape features differentiate schizoaffective disorder from schizophrenia.

30. Psychotic-like experiences among 9,564 Kenyan adolescents and young adults.

31. Three genetic-environmental networks for human personality.

33. Neurocognition in Kenyan youth at clinical high risk for psychosis.

34. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

35. Personality Traits as Markers of Psychosis Risk in Kenya: Assessment of Temperament and Character.

36. The psychometric properties of the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) screen in adults in the Kenyan context: Towards combined large scale community screening for affectivity and psychosis.

37. White matter integrity in schizophrenia and bipolar disorder: Tract- and voxel-based analyses of diffusion data from the Connectom scanner.

38. Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder.

39. Functional Connectivity of Cognitive Brain Networks in Schizophrenia during a Working Memory Task.

40. Tract-based analysis of white matter integrity in psychotic and nonpsychotic bipolar disorder.

41. Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.

42. Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.

43. Subcortical neuromorphometry in schizophrenia spectrum and bipolar disorders.

44. Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.

45. Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy.

46. The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden.

47. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder.

48. Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects.

49. Validation of a modified version of the PRIME screen for psychosis-risk symptoms in a non-clinical Kenyan youth sample.

50. Resting state functional connectivity of five neural networks in bipolar disorder and schizophrenia.

Catalog

Books, media, physical & digital resources